John Hardesty Bland, MD, professor of medicine emeritus at the University of Vermont College of Medicine in Burlington, died on March 15, 2007. He was midway through his 90th year, fulfilling the prescription of his last book, Live Long, Die Fast: Playing the Aging Game to Win, published when he was 80. A consummate rheumatologist and wonderful bedside doctor and teacher, Dr. Bland was also one of the genuine polymaths in the American medical world.
ACR Master Wins 2007 Leadership in Personalized Medicine Award
ACR Master Ralph Snyderman, MD, chancellor emeritus for health affairs at Duke University in Durham, N.C., and founder and chairman of Proventys Inc., recently received the 2007 Leadership in Personalized Medicine Award. The award, given by the Personalized Medicine Coalition (PMC), honors Dr. Snyderman’s efforts to advance predictive and targeted therapies on a national scale.
Osteonecrosis
Osteonecrosis, also called avascular necrosis or aseptic necrosis, is a condition in which the death of bone cells (due to decreased blood flow) can lead to pain and collapse of areas of bone. This collapse of bone, in turn, can lead to degenerative arthritis of nearby joints, most commonly the hips and knees. Less frequently affected are the shoulders, hands, and feet. In rare instances, osteonecrosis can occur in the jaw— resulting in pain and mouth ulceration. Osteonecrosis is not fatal, but can lead to pain, arthritis, problems with physical activity, and even the need for joint replacement. Most of the 10,000 to 20,000 Americans developing osteonecrosis annually are between age 20 and 50. These individuals usually have a history of serious trauma, corticosteroid use, excess alcohol intake, or other conditions including systemic lupus erythematosus, dysbarism (“the bends” that occur with scuba diving), blood disorders, HIV infection, and radiation therapy.
State-of-the-Art Clinical Symposium
The 2008 ACR State-of-the-Art Clinical Symposium will present current, cutting-edge information on a broad array of topics in rheumatology.
Marc C. Hochberg, MD, MPH, Named PI for Upcoming OA Guidelines
The ACR has named Marc C. Hochberg, MD, MPH, as the principal investigator (PI) for the upcoming, “Guidelines for the Management of Osteoarthritis [OA] of the Hip, Knee, and Hand.” Dr. Hochberg is professor of medicine and epidemiology and preventive medicine and head of the division of rheumatology and clinical immunology at the University of Maryland School of Medicine in Baltimore.
Does Secondary Gain Exist?
How I learned to balance the complex equation of loss and gain from disease
The Symptoms or the Disease
Where should we focus?
Preceptorship Applications Due February 1
The ACR REF/Abbott Health Professional Graduate Student Research Preceptorship introduces students to rheumatology-related healthcare by supporting a graduate student’s full-time research in the broad area of rheumatic disease.
New Merit Award Honors ARHP Advocate
Ann Kunkel, an advocate and healthcare profes- sional, knows the devastation arthritis can cause. All four of her children have some form of arthritis. “My kids have dealt with this disease for more than 20 years,” says Kunkel. The experience of raising four children with arthritis has been a driving force in Kunkel’s advocacy efforts for over 11 years.
2008 Keystone Pediatric Rheumatology Symposium
In 1976, a group of rheumatologists convened in Park City, Utah, to discuss the rheumatic diseases of childhood. In many ways, this was the beginning of the pediatric rheumatology subspecialty in the United States.
- « Previous Page
- 1
- …
- 215
- 216
- 217
- 218
- 219
- …
- 227
- Next Page »